Black Rock Inc. Dermata Therapeutics, Inc. Transaction History

Black Rock Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$115.2 - $319.2 $2.04 Million - $5.64 Million	-17,669 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$223.2 - $571.2 $2.09 Million - $5.34 Million	9,343 Added 112.21%	17,669 $22,000
Q4 2021 Feb 10, 2022	BUY	$374.4 - $1500.0 $964,079 - $3.86 Million	2,575 Added 44.77%	8,326 $15,000
Q3 2021 Nov 09, 2021	BUY	$1000.8 - $1392.0 $5.76 Million - $8.01 Million	5,751 New	5,751 $26,000

Ticker DRMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 10,102,200
Market Cap $15.8M
Description
Dermata Therapeutics, Inc., a clinical-stage biotechnology company, focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions. The company's lead product candidate is DMT310, which has completed Phase IIb clinical trial for treatment of moderate-to-severe ...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.